Rheumatology research output in the Arab World: despite the challenges
Submitted: 21 August 2022
Accepted: 3 October 2022
Published: 29 December 2022
Accepted: 3 October 2022
Abstract Views: 834
PDF: 443
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- S. Tanwar, B. Mattoo, U. Kumar, R. Dada, R. Bhatia, Does human serotonin-1A receptor polymorphism (rs6295) code for pain and associated symptoms in fibromyalgia syndrome? , Reumatismo: Vol. 73 No. 1 (2021)
- F.J. Aceves-Avila, M.A. Delgadillo-Ruano, C. Ramos-Remus, A. Gómez-Vargas, The “Hospital Real de San Josef de los Naturales” and the rheumatic conditions found in New Spain during sixteenth century , Reumatismo: Vol. 54 No. 1 (2002)
- B.K. Singh, S. Singh, Systemic lupus erythematosus and infections , Reumatismo: Vol. 72 No. 3 (2020)
- F. Salaffi, C.M. Vaccaro, T. Manacorda, L. Pardini, V. Coletta, C. Montecucco, Health-related quality of life in patients with rheumatoid arthritis: assessment by a Italian version of the Arthritis Impact Measurement Scales, Version 2 (AIMS2) , Reumatismo: Vol. 62 No. 1 (2010)
- R. Gualtierotti, L. Scalone, F. Ingegnoli, P. Cortesi, C. Lubatti, S. Zeni, P.L. Meroni, Health related quality of life assessment in patients with systemic sclerosis , Reumatismo: Vol. 62 No. 3 (2010)
- E. Özduran, V. Hanci, Evaluating the readability, quality and reliability of online information on Behçet’s disease , Reumatismo: Vol. 74 No. 2 (2022)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- M.S.M.S. Faria, S.K. Shinjo, COVID-19 as potential aggravating factor for the natural course of new onset-dermatomyositis , Reumatismo: Vol. 74 No. 1 (2022)
- G. Pasero, P. Marson, A short history of anti-rheumatic therapy - VI. Rheumatoid arthritis drugs , Reumatismo: Vol. 63 No. 2 (2011)
- M. Galeazzi, E. Balistreri, C. Giannitti, G.D. Sebastiani, MicroRNAs in autoimmune rheumatic diseases , Reumatismo: Vol. 64 No. 1 (2012)
<< < 29 30 31 32 33 34 35 36 37 38 > >>
You may also start an advanced similarity search for this article.